110 related articles for article (PubMed ID: 8697142)
1. Interferon-gamma and tumor necrosis factor-alpha treatment of ex vivo human carcinoma cells potentiates their interaction with allogeneic lymphocytes.
Vánky F; Hising C; Sjöwall K; Larsson B; Klein E
J Interferon Cytokine Res; 1996 Mar; 16(3):201-7. PubMed ID: 8697142
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon gamma and tumour necrosis factor alpha treatment of tumour cells potentiates their interaction with autologous blood lymphocytes.
Vánky F; Hising C; Sjöwall K; Larsson B; Rodriguez L; Orre L; Klein E
Cancer Immunol Immunother; 1995 Oct; 41(4):217-26. PubMed ID: 7489564
[TBL] [Abstract][Full Text] [Related]
3. Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro.
Vánky F; Wang P; Patarroyo M; Klein E
Cancer Immunol Immunother; 1990; 31(1):19-27. PubMed ID: 1968361
[TBL] [Abstract][Full Text] [Related]
4. Requirement of MHC class I antigen expression on human tumors for in vitro recognition by autologous blood lymphocytes.
Vánky F; Klein E
Semin Cancer Biol; 1991 Feb; 2(1):55-62. PubMed ID: 1680491
[TBL] [Abstract][Full Text] [Related]
5. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
6. Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on beta cells.
Kuttler B; Hartmann A; Wanka H
Transplantation; 2002 Aug; 74(4):440-5. PubMed ID: 12352900
[TBL] [Abstract][Full Text] [Related]
7. Primary human mesothelioma cells express class II MHC, ICAM-1 and B7-2 and can present recall antigens to autologous blood lymphocytes.
Mutti L; Valle MT; Balbi B; Orengo AM; Lazzaro A; Alciato P; Gatti E; Betta PG; Pozzi E
Int J Cancer; 1998 Dec; 78(6):740-9. PubMed ID: 9833768
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
9. Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.
Maio M; Gulwani B; Tombesi S; Ferrone S
Cancer Immunol Immunother; 1989; 30(1):34-42. PubMed ID: 2513111
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
11. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
[TBL] [Abstract][Full Text] [Related]
12. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
13. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
[TBL] [Abstract][Full Text] [Related]
14. Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
Darley R; Morris A; Passas J; Bateman W
Cancer Immunol Immunother; 1993 Jul; 37(2):112-8. PubMed ID: 8100485
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
16. Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.
Vánky F; Stuber G; Rotstein S; Klein E
Cancer Immunol Immunother; 1989; 28(1):17-21. PubMed ID: 2462466
[TBL] [Abstract][Full Text] [Related]
17. Tumor surveillance: expression of the transporter associated with antigen processing (TAP-1) in ex-vivo human tumor samples and its elevation by in vitro treatment with IFN-gamma and TNF-alpha.
Nagy N; Vánky F; Klein E
Immunol Lett; 1998 Dec; 64(2-3):153-60. PubMed ID: 9870667
[TBL] [Abstract][Full Text] [Related]
18. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV.
Salek-Ardakani S; Arrand JR; Mackett M
Virology; 2002 Dec; 304(2):342-51. PubMed ID: 12504574
[TBL] [Abstract][Full Text] [Related]
20. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
Akbasak A; Oldfield EH; Saris SC
J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]